Swathi Shrihari

4.6k total citations · 1 hit paper
12 papers, 670 citations indexed

About

Swathi Shrihari is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Swathi Shrihari has authored 12 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Animal Science and Zoology. Recurrent topics in Swathi Shrihari's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). Swathi Shrihari is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). Swathi Shrihari collaborates with scholars based in United States, Canada and Germany. Swathi Shrihari's co-authors include Michael Diamond, Emma S. Winkler, Rita E. Chen, Larissa B. Thackray, Pei‐Yong Shi, Laura A. VanBlargan, Pavlo Gilchuk, James E. Crowe, Rachel S. Nargi and Seth J. Zost and has published in prestigious journals such as Cell, The Journal of Immunology and Science Advances.

In The Last Decade

Swathi Shrihari

12 papers receiving 660 citations

Hit Papers

Neutralizing and protective human monoclonal antibodies r... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Swathi Shrihari
Swathi Shrihari
Citations per year, relative to Swathi Shrihari Swathi Shrihari (= 1×) peers Martin Müller

Countries citing papers authored by Swathi Shrihari

Since Specialization
Citations

This map shows the geographic impact of Swathi Shrihari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swathi Shrihari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swathi Shrihari more than expected).

Fields of papers citing papers by Swathi Shrihari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swathi Shrihari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swathi Shrihari. The network helps show where Swathi Shrihari may publish in the future.

Co-authorship network of co-authors of Swathi Shrihari

This figure shows the co-authorship network connecting the top 25 collaborators of Swathi Shrihari. A scholar is included among the top collaborators of Swathi Shrihari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swathi Shrihari. Swathi Shrihari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vanderheiden, Abigail, Elizabeth J. Elrod, Katharine Floyd, et al.. (2024). CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment. Science Advances. 10(34). eadp2636–eadp2636. 9 indexed citations
2.
Adams, Lucas J., Laura A. VanBlargan, Zhuoming Liu, et al.. (2023). A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection. Cell Reports Medicine. 4(12). 101305–101305. 5 indexed citations
3.
Ying, Baoling, Bradley Whitener, Laura A. VanBlargan, et al.. (2022). Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Science Translational Medicine. 14(630). eabm3302–eabm3302. 36 indexed citations
4.
Case, James Brett, Rita E. Chen, Longxing Cao, et al.. (2021). Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host & Microbe. 29(7). 1151–1161.e5. 40 indexed citations
5.
Hassan, Ahmed O., Swathi Shrihari, Matthew J. Gorman, et al.. (2021). An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Reports. 36(4). 109452–109452. 86 indexed citations
6.
Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 184(9). 2316–2331.e15. 215 indexed citations breakdown →
7.
Shrihari, Swathi, et al.. (2021). Thioredoxin-mediated alteration of protein content and cytotoxicity of Acinetobacter baumannii outer membrane vesicles. Experimental Biology and Medicine. 247(3). 282–288. 6 indexed citations
8.
Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. The Journal of Immunology. 206(1_Supplement). 30.13–30.13. 5 indexed citations
9.
Case, James Brett, Paul W. Rothlauf, Rita E. Chen, et al.. (2020). Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host & Microbe. 28(3). 465–474.e4. 115 indexed citations
10.
Winkler, Emma S., Swathi Shrihari, Barry L. Hykes, et al.. (2020). The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis. Cell. 182(4). 901–918.e18. 132 indexed citations
11.
Yu, Jieh‐Juen, Swathi Shrihari, J. Seshu, et al.. (2019). Thioredoxin Modulates Cell Surface Hydrophobicity in Acinetobacter baumannii. Frontiers in Microbiology. 10. 20 indexed citations
12.
Shrihari, Swathi. (2010). Pathogen Removal Under the Influence of Iron. World Academy of Science, Engineering and Technology, International Journal of Environmental, Chemical, Ecological, Geological and Geophysical Engineering. 4(12). 690–695. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026